Regulatory & Reimbursement
Pathways' Pick of the Week: Patient-Reported Outcomes
The challenges and opportunities of leveraging patient-reported outcomes (PROs) to support device regulatory decisions are getting attention at FDA meetings this week. In this latest Market Pathways' Pick of the Week: some expert tips on PROs from consultant and former FDA reviewer Kevin Go.
Read Article